Heme-linked ionization and ligand binding produce identical changes of proximal heme stereochemistry in reduced horseradish peroxidase Evidence for existence of two protein conformations  by Sharonov, Yurii A. et al.
Volume 235, number 1,2, 63-66 FEB 06121 August 1988 
Heme-linked ionization and ligand binding produce identical 
changes of proximal heme stereochemistry in reduced horseradish 
peroxidase 
Evidence for existence of two protein conformations 
Yurii A. Sharonov, Victor F. Pismensky and Elena G. Yarmola 
Institute of Molecular Biology, Academy of Sciences of the USSR, 117984 Moscow, USSR 
Received 1June 1988 
The visible and near infrared magnetic circular dichroism spectra of chemically reduced horseradish peroxidase at neutral 
and alkaline pH values and 5-coordinate protoheme-(2-methylimidazole) at pH 9. I were compared at 4.2 K with those 
of photolysis products of their carbon monoxide complexes. From the results obtained we concluded that: (i) there are 
two protein conformations of HRP which determine the geometry of the Fe-N(His) bond; (ii) the transition from one 
conformation (heme stereochemistry) to another can be induced by either heme-linked ionization or ligand binding; (iii) 
a trigger mechanism for switching between two conformations has to exist. 
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1. INTRODUCTION 
Theorell was the first who observed the presence 
of a heme-linked ionization group in reduced HRP 
[ 11. Later, the changes of the heme group proper- 
ties following ionization of a group with a pK 
value of 7.2 were registered and studied by optical 
spectroscopy [2], pH-stat titration [2], MCD [3], 
RR scattering [4] and ‘H-NMR [5] methods. The 
linkage of the heme spectral characteristics with 
ionization of amino acid residues is a common 
feature for plant peroxidases but the pK values de- 
pend on the species and they are quite different for 
various isoenzymes from the same source [6]. 
In this paper we compare at 4.2 K the visible and 
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the near infrared MCD spectra of neutral and 
alkaline forms of reduced HRP in their 
equilibrium and non-equilibrium conformations 
generated by chemical reduction of oxidized en- 
zyme at room temperature before freezing of the 
sample and by low-temperature photolysis of their 
CO complexes, respectively. We demonstrate for 
the first time that such different perturbations as 
heme-linked ionization and binding of a ligand to 
the heme iron produce identical changes in the pro- 
ximal heme stereochemistry. The photolysis ex- 
periments for CO-protoheme-(2-MeIm) are 
described and compared with those for HRP. 
2. MATERIALS AND METHODS 
HRP (Worthington, R.Z. 3.0), protohemin (Sigma, type I) 
and 2-MeIm (a kind gift from Dr G.D. Rudkovskaya) were used 
without further purification. Enzyme was dissolved in 0.2 M 
sodium phosphate (pH 6.0 and 6.8) or glycine-phosphate (pH 
10.2) buffers. The 5-coordinate model compound was prepared 
from protohemin in 0.05 M borate buffer (pH 9.1) by adding 
2-MeIm to a concentration of 0.1 M: To obtain transparent 
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glasses for low-temperature measurements the stock solutions 
were mixed with a purifed glycerol (1: 1.5, v/v). Ferric HRP 
and protohemin were reduced by a few grains of sodium 
dithionite (Merck) after deoxygenation of solutions under moist 
helium. CO forms were prepared by equilibration of the re- 
duced samples with CO at 1 atm. All measurements were car- 
ried out in a contact-type quartz cell with a light path of 1 mm. 
The MCD measurements and photolysis experiments were per- 
formed at 4.2 K as described earlier [7] by using a home-made 
dichrograph fitted with an electromagnet and equipped with a 
helium cryostat. 
3. RESULTS 
Fig.1 shows the MCD spectra at 4.2 K of re- 
duced HRP and metastable photoproducts of CO- 
complexes at pH values of 6.0 and 10.2. The 
shaded region outlines the spectra of the photolysis 
products at both pH 6.0 and 10.2 and of the 
equilibrium reduced enzyme at pH 10.2. Some of 
the differences observed in the MCD intensity can 
be partially explained by the errors in the 
measurements due to light depolarization as a 
result of strains and cracks in the glassy samples. 
The three spectra are very similar over the entire 
spectral region and differ drastically from those of 
the equilibrium reduced enzyme at pH 6.0. We 
have not observed any detectable distinctions be- 
tween the MCD spectra of reduced HRP prepared 
at pH 6.0 and pH 6.8 or in 0.02 and 0.2 M 
phosphate buffer. Thus only two types of spectra 
could be observed for reduced HRP and the 
metastable photoproducts at the various pH and 
ionic strength values examined. 
Fig.1. MCD spectra of carbon monoxide photoproducts and 
reduced preparations of HRP at 4.2 K. Photoproducts at pH 
6.0 ( * - -) and 10.2 (- - -); reduced HRP at pH 6.0 (-) and 
10.2 (-----). Enzyme concentration, 3.2x 10m4 M; magnetic 
field, 1.45 T. 
4.2 K 
-4OL ’ I ._ I I 
550 650 750 nnl 
Fig.2. MCD spectra of protoheme-(2-MeIm) (solid line) and 
photolysis product of its carbon monoxide complex (dotted 
line) at 4.2 K. Heme concentration, 1 x IO-’ M; magnetic field, 
1.45 T. 
Fig.2 displays the result of photolysis experi- 
ment for protoheme-(2-MeIm). On lowering the 
temperature, the high-spin 5coordinate model 
heme compound was partially and reversibly con- 
verted into the low-spin form [3,8]. The content of 
the low-spin species depended on porphyrin substi- 
tuents, 2-MeIm concentration and the freezing rate 
and did not exceed 10% in our experiment. The 
low-spin forms lack bands in the near infrared 
region while in the visible MCD their presence ap- 
pears only as a shoulder at 550 nm. Negligible con- 
tribution of the low-spin form in the MCD at 
cryogenic temperatures is due to the fact that its 
MCD is temperature independent, while the MCD 
intensity of the high-spin form increases by a fac- 
tor of about 70 on cooling the sample from 300 to 
4.2 K. 
4. DISCUSSION 
At room temperature, no differences have been 
observed in the transient time-resolved 7-ns RR 
spectrum for the photoproducts of HRP-CO at 
neutral pH values [lO,l l] as compared with the 
reduced enzyme including the Fe-His stretching 
mode, whose frequency was shifted from 244 to 
241 cm-’ by heme-linked ionization of reduced 
HRP [4]. Our experiments uggest hat in the RR 
studies at room temperature the photoproducts 
have presumably fully relaxed on the 7-ns time 
scale. Similar nanosecond relaxation has been 
observed in the photolysis experiments for MbCO 
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112,131, but unrelaxed photoproducts were 
detected on the 25-ps time scale at room 
temperature [14]. What’s more the shift of the Fe- 
His stretching mode between deoxy-Mb and the 
carbon monoxide photoproduct undetectable in 
the time-resolved 35~s experiment at room 
temperature [15] was observed for the metastable 
photoproduct at 4 K [16]. 
Fig.2 shows that at 4.2 K the stereochemistry of 
the photoproduct remains unrelaxed even for 
protein-free heme bound with 2-MeIm. For the 
CO-protoheme-(2-MeIm) photoproduct the high- 
spin bands at -680 and -760 nm are red shifted 
relative to their equilibrium positions on the values 
typical for the protein bound heme [7,17]. Earlier 
the correlation was established between the 
energies of these bands and those of the Fe-pyrrols 
and Fe-His bonds. Therefore after photolysis at 
cryogenic temperatures the geometry of the Fe- 
porphyrin and the Fe-His bonds in the metastable 
photoproduct can be considered to be similar to 
that in a ligand bound heme. 
From our results we concluded that: (i) there are 
no changes in a geometry of the Fe-His bond or 
they are very small upon ligand binding to the 
heme of alkaline HRP; (ii) the ligand binding to 
neutral HRP is accompanied with a significant 
rearrangement of the proximal heme stereo- 
chemistry; (iii) heme-linked ionization and ligand 
binding produce identical changes in the geometry 
of the Fe-His bond in neutral HRP; (iv) there are 
no detectable distinctions between the photo- 
products for neutral and alkaline HRP. The latter 
observation suggests that the pH-dependent iso- 
merization of the Fe-CO bond observed in CO- 
HRP [ 18,191 either does not affect the Fe-His bond 
or only one of two possible isomers is stablized at 
low temperatures. 
Alkaline HRP is the first example known to us 
where no red shift of the near infrared bands were 
observed in the photoproduct at cryogenic 
temperature as compared with the equilibrium 
preparation. We interpret this fact as the existence 
of a rigid correlation between the geometry of the 
Fe-His bond and the protein conformation. The 
energy of conformation rearrangement required 
for the heme stereochemistry changes is so high 
that the Fe-His bond remains unchanged on ligand 
binding. The conformation ‘pressure’ on the prox- 
imal heme stereochemistry of neutral HRP is 
weaker than that on alkaline HRP and ligand bind- 
ing is followed by changes of the Fe-His bond 
geometry and of the protein conformation [20]. 
In conclusion, (i) the ferrous HRP can exist in two 
conformations, two tertiary structures that deter- 
mine the proximal heme stereochemistry; (ii) the 
transition between these two conformations can be 
induced by either heme-linked ionization or ligand 
binding to the heme; (iii) a trigger mechanism for 
switching between the two conformations most 
probably exists. The contribution of conformation 
to the proximal heme stereochemistry of hemopro- 
teins and a possible role for the two conformations 
observed in the catalysis of HRP are discussed 
elsewhere [2 1,221. 
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